human
metapneumoviru
infecti
mononucleosi
mononucleosislik
ill
summari
man
present
incident
find
neutropenia
atyp
lymphocytosi
thrombocytopenia
derang
liver
parenchym
enzym
four
day
later
develop
fever
sore
throat
cervic
lymphadenopathi
compat
mononucleosislik
ill
mli
polymeras
chain
reaction
pcr
viral
cultur
nasopharyng
swab
show
human
metapneumoviru
hmpv
rise
igg
hmpv
first
case
report
illustr
natur
clinic
cours
hmpvrelat
mli
human
metapneumoviru
hmpv
recent
identifi
respiratori
viru
belong
famili
paramyxovirida
associ
acut
respiratori
tract
infect
children
clinic
syndrom
describ
adult
includ
influenzalik
ill
bronchiti
exacerb
asthma
chronic
obstruct
pulmonari
diseas
sever
pneumonia
also
occur
elderli
immunocompromis
patient
sever
hmpv
outbreak
involv
adult
resid
psychiatr
unit
longterm
care
facil
report
case
die
one
studi
case
report
present
natur
evolut
mononucleosislik
ill
mli
due
hmpv
immunocompet
adult
male
health
care
worker
present
incident
find
abnorm
blood
test
routin
health
check
complet
blood
pictur
reveal
normal
total
white
cell
count
l
howev
neutropenia
l
normal
rang
l
lymphocytosi
l
normal
rang
l
thrombocytopenia
platelet
l
normal
rang
l
review
blood
smear
show
presenc
atyp
lymphocyt
l
normal
rang
platelet
clump
fig
liver
parenchym
enzym
derang
elev
alanin
aminotransferas
ul
normal
rang
ul
aspart
aminotransferas
ul
normal
rang
ul
gammaglutamyltransferas
alkalin
phosphatas
albumin
renal
function
test
within
normal
limit
view
abnorm
blood
pictur
flow
cytometri
studi
perform
next
day
demonstr
revers
ratio
suggest
reactiv
chang
due
viral
infect
extens
microbiolog
investig
mli
perform
day
serum
heterophil
antibodi
monospot
test
neg
epsteinebarr
viru
ebv
serolog
show
past
infect
posit
ebna
vca
igg
cytomegaloviru
cmv
igg
posit
igm
neg
cmv
antigenemia
neg
serum
hiv
antibodi
toxoplasma
parvoviru
igm
igg
also
neg
day
abnorm
blood
test
patient
develop
symptom
upper
respiratori
tract
infect
includ
sore
throat
rhinorrhoea
product
cough
myalgia
also
develop
bilater
cervic
lymphadenopathi
progress
increas
day
view
multipl
cervic
lymphadenopathi
hematolog
abnorm
comput
tomographi
contrast
neck
thorax
abdomen
perform
assess
extent
lymphadenopathi
multipl
mildli
enlarg
node
along
right
jugulodigastr
chain
level
iii
iv
v
largest
one
measur
cm
apex
right
posterior
triangl
neck
enlarg
lymphadenopathi
region
microbiolog
investig
perform
upon
symptom
onset
includ
nasopharyng
swab
np
throat
swab
bacteri
cultur
viral
antigen
detect
influenza
influenza
b
parainfluenza
type
adenoviru
respiratori
syncyti
viru
viral
cultur
nasopharyng
swab
buffi
coat
test
hmpv
rhinoviru
human
coronaviru
enteroviru
revers
transcript
polymeras
chain
reaction
rtpcr
buffi
coat
human
herpesviru
type
parvoviru
pcr
also
assay
np
posit
fragment
polymeras
gene
hmpv
rtpcr
confirm
sequenc
pcr
product
acut
convalesc
sera
taken
day
apart
test
igg
antibodi
hmpv
show
rise
titr
viral
cultur
np
also
posit
hmpv
clinic
isol
found
genotyp
b
microbiolog
investig
neg
repeat
blood
test
show
gradual
recoveri
blood
count
decreas
atyp
lymphocytosi
tabl
complet
blood
pictur
liver
parenchym
enzym
normal
day
later
upon
question
patient
daughter
histori
fever
c
day
health
check
babi
also
develop
similar
upper
respiratori
symptom
patient
apart
daughter
patient
known
contact
peopl
upper
respiratori
tract
symptom
least
week
onset
ill
aliquot
np
sampl
test
hmpv
viral
rna
extract
directli
np
specimen
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
rna
pellet
resuspend
ml
dnasefre
rnasefre
doubledistil
water
use
templat
rtpcr
fragment
polymeras
gene
hmpv
amplifi
rtpcr
use
primer
lpw
lpw
aaayt
rna
convert
cdna
combin
randomprim
strategi
use
superscript
ii
kit
invitrogen
san
diego
ca
usa
pcr
mixtur
ml
contain
ml
cdna
pcr
buffer
mm
trisehcl
ph
mm
kcl
mm
mgcl
gelatin
mm
dntp
u
taq
polymeras
boehring
mannheim
germani
mixtur
amplifi
cycl
c
min
c
min
c
min
final
extens
c
min
autom
thermal
cycler
perkineelm
cetu
gouda
netherland
pcr
product
gelpurifi
use
qiaquick
gel
extract
kit
qiagen
hilden
germani
strand
pcr
product
sequenc
twice
abi
prism
dna
analyz
appli
biosystem
foster
citi
ca
usa
use
pcr
primer
hmpv
cultur
cell
monolay
cultur
tube
inocul
ml
np
cell
maintain
serum
free
medium
mem
minim
essenti
medium
trypsin
mgml
incub
c
day
examin
daili
cytopath
effect
cpe
immunofluoresc
done
fix
cell
smear
cpe
appear
end
incub
period
hmpv
antibodi
detect
perform
use
indirect
immunofluoresc
test
hmpvinfect
cell
smear
fig
briefli
serum
serial
dilut
start
screen
infect
noninfect
control
cell
min
c
cell
wash
twice
phosphatebuff
salin
min
time
antihuman
igg
fluorescein
isothiocyan
conjug
inova
diagnost
san
diego
ad
cell
incub
min
c
ifdyestain
cell
examin
magnif
uv
fluoresc
microscop
infecti
mononucleosi
classic
associ
ebv
howev
mani
infect
mimic
condit
label
mli
ebv
cmv
consid
common
infect
caus
mli
associ
fever
atyp
lymphocytosi
mild
hepat
sore
throat
lymphadenopathi
typic
absent
infect
caus
includ
herp
simplex
viru
type
human
herpesviru
type
hiv
parvoviru
adenoviru
streptococcu
pyogen
toxoplasma
howev
previou
report
suggest
relationship
mli
hmpv
present
case
report
patient
mli
due
hmpv
presenc
hmpv
document
pcr
later
confirm
viral
cultur
evid
acut
hmpv
infect
shown
rise
antihmpv
antibodi
pair
serum
clinic
manifest
mli
support
abnorm
laboratori
find
includ
presenc
atyp
lymphocyt
abnorm
level
liver
parenchym
enzym
infecti
caus
mli
exclud
extens
microbiolog
investig
incident
find
abnorm
blood
test
health
checkup
provid
uniqu
opportun
studi
case
demonstr
hematolog
abnorm
demonstr
earli
day
acquir
viru
howev
recent
serial
blood
test
abnorm
result
therefor
abl
pinpoint
exact
onset
abnorm
blood
test
anoth
promin
featur
patient
mark
thrombocytopenia
mild
thrombocytopenia
common
among
classic
infecti
mononucleosi
howev
sever
thrombocytopenia
rare
immun
relat
destruct
postul
autoantibodi
platelet
glycoprotein
gpiibiiia
gpibix
platelet
plasma
report
patient
infecti
mononucleosi
current
approv
treatment
hmpv
ribavirin
demonstr
effect
mice
tri
post
heartelung
transplant
patient
hmpv
infect
sinc
caus
seriou
lifethreaten
ill
anoth
safer
antivir
drug
diseas
urgent
need
first
case
report
clearli
document
abil
hmpv
caus
mli
immunocompet
host
prospect
follow
presymptomat
stage
studi
requir
identifi
preval
hmpvrelat
mli
